INSP Inspire Medical Systems Inc

  1. Stocks
  2. Healthcare
  3. NYSE: INSP

Price (delayed)

$198.44

Market cap

$5.82B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.41

Enterprise value

$5.38B

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the ...

Highlights
The company's equity has surged by 133% YoY and by 4.9% QoQ
Inspire Medical Systems's revenue has soared by 75% YoY and by 13% from the previous quarter
The company's quick ratio has surged by 58% YoY but it fell by 7% QoQ
The company's gross margin fell by 2.1% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inspiremedicalsystems.com
Peers: PDEX OFIX NVRO

Key stats

What are the main financial stats of INSP
Market
Shares outstanding
29.34M
Market cap
$5.82B
Enterprise value
$5.38B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.94
Price to sales (P/S)
11.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.22
Earnings
Revenue
$526.08M
EBIT
-$39.62M
EBITDA
-$36.17M
Free cash flow
$18.95M
Per share
EPS
-$1.41
Free cash flow per share
$0.65
Book value per share
$18.15
Revenue per share
$18
TBVPS
$21.15
Balance sheet
Total assets
$618.25M
Total liabilities
$88.89M
Debt
$22.05M
Equity
$529.36M
Working capital
$493.39M
Liquidity
Debt to equity
0.04
Current ratio
8.4
Quick ratio
7.96
Net debt/EBITDA
12.3
Margins
EBITDA margin
-6.9%
Gross margin
83.6%
Net margin
-7.8%
Operating margin
-10.2%
Efficiency
Return on assets
-7.2%
Return on equity
-8.2%
Return on invested capital
-49.3%
Return on capital employed
-7.2%
Return on sales
-7.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSP stock price

How has the Inspire Medical Systems stock price performed over time
Intraday
-0.97%
1 week
7.26%
1 month
-12.79%
1 year
12.04%
YTD
-21.22%
QTD
-38.87%

Financial performance

How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$526.08M
Gross profit
$440M
Operating income
-$53.63M
Net income
-$41.07M
Gross margin
83.6%
Net margin
-7.8%
Inspire Medical Systems's revenue has soared by 75% YoY and by 13% from the previous quarter
The gross profit has soared by 71% YoY and by 13% from the previous quarter
INSP's net margin is up by 47% YoY and by 17% QoQ
The operating income has declined by 29% year-on-year and by 5% since the previous quarter

Growth

What is Inspire Medical Systems's growth rate over time

Valuation

What is Inspire Medical Systems stock price valuation
P/E
N/A
P/B
10.94
P/S
11.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.22
INSP's EPS is up by 12% year-on-year and by 8% since the previous quarter
The company's equity has surged by 133% YoY and by 4.9% QoQ
The P/B is 34% below the 5-year quarterly average of 16.5 and 22% below the last 4 quarters average of 14.1
Inspire Medical Systems's revenue has soared by 75% YoY and by 13% from the previous quarter
The stock's P/S is 54% less than its 5-year quarterly average of 24.1 and 31% less than its last 4 quarters average of 16.1

Efficiency

How efficient is Inspire Medical Systems business performance
INSP's ROE has soared by 58% year-on-year and by 20% since the previous quarter
INSP's ROA has soared by 53% YoY and by 19% from the previous quarter
INSP's return on sales is up by 46% year-on-year and by 16% since the previous quarter
INSP's ROIC is up by 10% from the previous quarter and by 10% YoY

Dividends

What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSP.

Financial health

How did Inspire Medical Systems financials performed over time
The company's total assets has surged by 112% YoY and by 8% QoQ
The company's quick ratio has surged by 58% YoY but it fell by 7% QoQ
INSP's debt is 96% lower than its equity
The company's equity has surged by 133% YoY and by 4.9% QoQ
INSP's debt to equity has dropped by 69% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.